[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350471-105":59,"doc-detail-350471-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","long-term-survival-and-risk-of-second-malignant-neoplasms-among-childhood-cancer-patients-in-16-provinces-of-spain-research-findings","Long-Term Survival and Risk of Second Malignant Neoplasms Among Childhood Cancer Patients in 16 Provinces of Spain - Research Findings","","Childhood cancer survivors show substantially improved long-term survival, yet they remain at elevated risk of later malignancies driven largely by treatments received during childhood. This population-based analysis in Spain evaluates survival trends by tumor type and quantifies short- and medium-term risk of second malignant neoplasms (SMNs) by time since diagnosis and tumor category. Evidence from multiple cancer registries supports strategy development to improve survival and reduce treatment-related toxicity through optimized follow-up care.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/long-term-survival-and-risk-of-second-malignant-neoplasms-among-childhood-cancer-patients-in-16-provinces-of-spain-research-findings/350471/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/long-term-survival-and-risk-of-second-malignant-neoplasms-among-childhood-cancer-patients-in-16-provinces-of-spain-research-findings/350471.png","ImageObject",300,407,{"name":92,"@type":93},"Aran","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on childhood cancer survivors in Spain?","Question",{"text":112,"@type":113},"To evaluate survival trends by tumor type and quantify the short- and medium-term risk of second malignant neoplasms (SMNs) by time since diagnosis and tumor category.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the study conducted and what data sources were used?",{"text":117,"@type":113},"The population-based registry study used data from cancer registries within the Spanish Network of Cancer Registries (REDECAN). It included malignancies and non-malignant CNS tumors diagnosed before age 15.",{"name":119,"@type":110,"acceptedAnswer":120},"What statistical approaches were used to estimate SMN risk and survival?",{"text":121,"@type":113},"Age-standardized incidence rates for 2015–2019 were calculated, five- and 10-year age-adjusted observed survival rates were estimated for earlier diagnosis periods, and SMN risk was assessed using standardized incidence ratios.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350471,1790535932,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nLong-Term Survival and Risk of Second Malignant Neoplasms Among Childhood Cancer Patients in 16 Provinces of Spain  \nJaume Galceran 1,2, *, Alberto Ameijide 1,2, Noura Jeghalef 3, Antonia Sánchez 4,5, Marcela Guevara 6,7,8, Jàmnica Bigorra 1,2, Pilar Gutiérrez 9, An L. D. Boone 10, Montserrat Garrido 11, Xitama Álvarez 11, Ana Vizcaíno 12, Isabel Martín 13, Amaia Onaindia 13, Silvia Sanclemente 13, Jan Trallero 14,15,16, María José Sánchez 8,17,18, María-Isabel Palacios 19, Ramon Clèries 20,21,22, Marià Carulla 1,2  \nand on behalf of the Spanish Network of Cancer Registries (REDECAN)  \nAcademic Editor: Eduardo Bruera  \nReceived: 20 May 2026  \nRevised: 11 June 2026  \nAccepted: 16 June 2026  \nPublished: 18 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Tarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Sant Joan de Reus University Hospital,  \n43204 Tarragona, Spain; [alberto.ameijide@salutsantjoan.cat](alberto.ameijide@salutsantjoan.cat) (A.A.); [jamnica.bigorra@salutsantjoan.cat](jamnica.bigorra@salutsantjoan.cat) (J.B.);  \n[maria.carulla@salutsantjoan.cat](maria.carulla@salutsantjoan.cat) (M.C.)  \n2 Institut de Recerca Biomèdica Catalunya Sud (IRBCatSud), 43204 Reus, Spain  \n3 Registry of Childhood and Adolescent Tumours of the Valencian Community, Generalitat Valenciana, 46010 Valencia, Spain; [jeghalef_nou@gva.es](jeghalef_nou@gva.es)  \n4 Murcia Cancer Registry, Department of Epidemiology, Regional Health Authority, 30008 Murcia, Spain; [antonia.sanchez20@carm.es](antonia.sanchez20@carm.es)  \n5 Instituto Murciano de Investigación Biosanitaria (IMIB)—Arrixaca, 30120 Murcia, Spain  \n6 Navarra Cancer Registry, Instituto de Salud Pública y Laboral de Navarra, 31003 Pamplona, Spain;  \nmp.guevara.eslava@navarra.es  \n7 Epidemiology and Public Health Area, Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain  \n8 CIBER DE Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; [mariajose.sanchez.easp@juntadeandalucia.es](mariajose.sanchez.easp@juntadeandalucia.es)  \n9 Castilla y León Cancer Registry, Public Health Directorate, Castilla y León Government,  \n47007 Valladolid, Spain; [pilar.gutierrez@jcyl.es](pilar.gutierrez@jcyl.es)  \n10 Registro de Tumores de Asturias, Dirección General de Salud Pública y Atención a la Salud Mental,  \n33005 Oviedo, Spain; [anlievedirk.boone@asturias.org](anlievedirk.boone@asturias.org)  \n11 Canary Islands Cancer Registry, Public Health Directorate, Canary Islands Government, 38003 Tenerife, Spain; [mcgarmary@gobiernodecanarias.org](mcgarmary@gobiernodecanarias.org) (M.G.); [xalvdia@gobiernodecanarias.org](xalvdia@gobiernodecanarias.org) (X.Á .)  \n12 Castellón Cancer Registry, Directorate General of Public Health, Generalitat Valenciana,  \n12003 Castellón, Spain; [vizcaino_ana@gva.es](vizcaino_ana@gva.es)  \n13 Basque Country Cancer Registry, Department of Health, Basque Government, 01010 Vitoria-Gasteiz, Spain; i-martinmunoz@euskadi.eus (I.M.); a-onaindiaagundez@euskadi.eus (A.O.);  \nms-sanclemente@euskadi.eus (S.S.)  \n14 Epidemiology Unit and Girona Cancer Registry, Catalan Institute of Oncology, 17190 Girona, Spain; [jtrallero@iconcologia.net](jtrallero@iconcologia.net)  \n15 Girona Biomedical Research Institute Dr. Josep Trueta (IDIBGI-CERCA), 17190 Girona, Spain  \n16 Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, 17004 Girona, Spain  \n17 Escuela Andaluza de Salud Pública, 18011 Granada, Spain  \n18 Instituto de Investigación Biosanitaria de Granada Ibs.GRANADA, 18012 Granada, Spain  \n19 La Rioja Cancer Registry, Servicio de Epidemiología y Prevención Sanitaria, Dirección General de Salud Pública, Consumo y Cuidados, 26071 Logroño, Spain; [mipalaciosc@riojasalud.es](mipalaciosc@riojasalud.es)  \n20 Catalan Cancer Plan, Health Department, Cata","cbCaifeRlNrSgA0N","https://ap.wps.com/l/cbCaifeRlNrSgA0N","pdf",1068310,21,"English","# Background and Objectives\n## Study Design and Population\n## Survival Estimation and Incidence Measures\n## SMN Risk Assessment\n## Implications for Follow-up Care","[{\"question\":\"What is the main goal of the study on childhood cancer survivors in Spain?\",\"answer\":\"To evaluate survival trends by tumor type and quantify the short- and medium-term risk of second malignant neoplasms (SMNs) by time since diagnosis and tumor category.\"},{\"question\":\"How was the study conducted and what data sources were used?\",\"answer\":\"The population-based registry study used data from cancer registries within the Spanish Network of Cancer Registries (REDECAN). It included malignancies and non-malignant CNS tumors diagnosed before age 15.\"},{\"question\":\"What statistical approaches were used to estimate SMN risk and survival?\",\"answer\":\"Age-standardized incidence rates for 2015–2019 were calculated, five- and 10-year age-adjusted observed survival rates were estimated for earlier diagnosis periods, and SMN risk was assessed using standardized incidence ratios.\"}]","Long-Term Survival and Risk of Second Malignant Neoplasms Among Childhood Cancer Patients in 16 Provinces of Spain - Research Findings | PDF",1790089221,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/acb416c350074082b3a32e2de23dfd5d.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20b5c3416b11ba058363d756b3ca5b74.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26e42e0a56521cf552e61327d08623f0.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5920be36ceb794c37c0e336c92bdb928.webp",980,1385]